Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis
- 13 April 2010
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1193 (1), 139-145
- https://doi.org/10.1111/j.1749-6632.2009.05367.x
Abstract
In order to identify rate and stability of remission induced by low-dose prednisone comedication in early rheumatoid arthritis (RA), we evaluated patients with early RA (<1 year) who were randomized to receive (P) or not (non-P) low-dose prednisone in association with step-up disease-modifying antirheumatic drug therapy over 2 years. Prevalence and duration of clinical remission were evaluated in the first and second year. Each treatment group included 105 patients; no significant differences were found at baseline. During the first year, P patients achieved higher rates of clinical remission with a time-averaged odds ratio (OR) of 1.965 (CI 95% 1.214-3.182, P= 0.006). Moreover, they showed a higher probability of sustained remission during the second year (OR 4.480, CI 95% 1.354-14.817, P= 0.014). In conclusion, we found as in early RA low-dose prednisone comedication is associated with higher rate of clinical remission, earlier disease activity control and more stable remission over time.Keywords
This publication has 20 references indexed in Scilit:
- Are Glucocorticoids DMARDs?Annals of the New York Academy of Sciences, 2006
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trialArthritis & Rheumatism, 2005
- Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2005
- Low‐dose prednisolone in addition to the initial disease‐modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two‐year randomized trialArthritis & Rheumatism, 2005
- Glucocorticoids in the treatment of early and late RAAnnals Of The Rheumatic Diseases, 2003
- Glucocorticoids in Rheumatoid ArthritisAnnals of the New York Academy of Sciences, 2002
- Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialAnnals of Internal Medicine, 2002
- Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study GroupRheumatology, 1998
- Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisThe Lancet, 1997
- The Effect of Glucocorticoids on Joint Destruction in Rheumatoid ArthritisThe New England Journal of Medicine, 1995